Volume 1, Issue 41

Science-Business eXchange is now archived and no longer receiving submissions with this publisher. All articles published in the journal during its time with Springer will remain fully searchable through our websites.

Search all Science-Business eXchange articles

November 2008

24 articles in this issue

Prostate-bound nanoparticles
Kai-Jye Lou
BriefCommunication Pages: 988 - 988
PLAyground in Alzheimer's
Lev Osherovich
BriefCommunication Pages: 989 - 989
MELOE target for melanoma
Lauren Martz
BriefCommunication Pages: 990 - 990
ArmaGen's gatecrashers
Tim Fulmer
OriginalPaper Pages: 991 - 991
Chemokine (C-X-C motif) receptor 4 (CXCR4); chemokine (C-X-C motif) ligand 12 (stromal cell–derived factor 1) (CXCL12; SDF-1α)

BriefCommunication Pages: 992 - 992
B cell CLL/lymphoma 2 (BCL2; BCL-2); BCL2-like 11 (BCL2_L11; BIM); mitogen-activated protein kinase kinase kinase 1 (MAP3K1; MEK)

BriefCommunication Pages: 993 - 993
B cell CLL/lymphoma 2 (BCL2; BCL-2); DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 (DDX58; RIG-I)

BriefCommunication Pages: 994 - 994
Unknown

BriefCommunication Pages: 995 - 995
Pancreatic β-cells

BriefCommunication Pages: 996 - 996
Prolactin-releasing hormone (PRLH; PRRP)

BriefCommunication Pages: 997 - 997
RNA-editing ligase 1 (REL1)

BriefCommunication Pages: 998 - 998
Phospholipase A₂, group IVA (cytosolic, calcium-dependent) (PLA₂G4A)

BriefCommunication Pages: 999 - 999
Phosphorylated-τ 231 (p-τ 231); sirtuin 1 (SIRT1)

BriefCommunication Pages: 1000 - 1000
Mast cells

BriefCommunication Pages: 1001 - 1001
β-catenin

BriefCommunication Pages: 1002 - 1002
Protein kinase, cAMP-dependent, catalytic, α (PRKACA; PKACA); protein kinase, X-linked (PRKX); patatin-like phospholipase domain containing 6 (PNPLA6; NTE)

BriefCommunication Pages: 1003 - 1003
Droplet interface bilayer array for rapid screening

BriefCommunication Pages: 1004 - 1004
In vitro assay to predict responses to acute lymphoblastic leukemia (ALL) treatment

BriefCommunication Pages: 1005 - 1005
Genetically engineered mouse models of cancer

BriefCommunication Pages: 1006 - 1006
Arg-Gly-Asp-Lys (RGDK) lipopeptide for cancer gene delivery to tumor vasculature

BriefCommunication Pages: 1007 - 1007
Fusion protein for drug delivery across the blood-brain barrier (BBB)

BriefCommunication Pages: 1008 - 1008
Attenuated bacterial strains to treat cancer

BriefCommunication Pages: 1009 - 1009
Recombinant meganucleases to treat genetic diseases

BriefCommunication Pages: 1010 - 1010
MRI-based computational model to differentiate between malignant and benign breast tumors

BriefCommunication Pages: 1011 - 1011

Volume 1, Issue 41

Prostate-bound nanoparticles

PLAyground in Alzheimer's

MELOE target for melanoma

ArmaGen's gatecrashers

Chemokine (C-X-C motif) receptor 4 (CXCR4); chemokine (C-X-C motif) ligand 12 (stromal cell–derived factor 1) (CXCL12; SDF-1α)

B cell CLL/lymphoma 2 (BCL2; BCL-2); BCL2-like 11 (BCL2_L11; BIM); mitogen-activated protein kinase kinase kinase 1 (MAP3K1; MEK)

B cell CLL/lymphoma 2 (BCL2; BCL-2); DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 (DDX58; RIG-I)

Unknown

Pancreatic β-cells

Prolactin-releasing hormone (PRLH; PRRP)

RNA-editing ligase 1 (REL1)

Phospholipase A₂, group IVA (cytosolic, calcium-dependent) (PLA₂G4A)

Phosphorylated-τ 231 (p-τ 231); sirtuin 1 (SIRT1)

Mast cells

β-catenin

Protein kinase, cAMP-dependent, catalytic, α (PRKACA; PKACA); protein kinase, X-linked (PRKX); patatin-like phospholipase domain containing 6 (PNPLA6; NTE)

Droplet interface bilayer array for rapid screening

In vitro assay to predict responses to acute lymphoblastic leukemia (ALL) treatment

Genetically engineered mouse models of cancer

Arg-Gly-Asp-Lys (RGDK) lipopeptide for cancer gene delivery to tumor vasculature

Fusion protein for drug delivery across the blood-brain barrier (BBB)

Attenuated bacterial strains to treat cancer

Recombinant meganucleases to treat genetic diseases

MRI-based computational model to differentiate between malignant and benign breast tumors

Navigation